Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs
* Clinical safety and efficacy * Initiation and titration * Administration considerations * Individualizing treatment
Be the first to comment
Sign up now and become a member of the Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs community!
Then 99 kr. / month · Cancel anytime.
4 episodes
Clinical Case Vignettes
* Initiating triheptanoin * Dosing modification to improve tolerability
Optimizing Triheptanoin Therapy
Historical Treatment; Introduction of Triheptanoin
* Dietary modification * MCT supplementation * Triheptanoin mechanism of action
Understanding LC-FAODs
* Autosomal recessive inheritance * Carnitine shuttle * Newborn screening * Clinical features
Comments
0Be the first to comment
Sign up now and become a member of the Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs community!